48,830
edits
Difference between revisions of "ELOC-mutated renal cell carcinoma"
Jump to navigation
Jump to search
ELOC-mutated renal cell carcinoma (view source)
Revision as of 20:39, 16 November 2023
, 20:39, 16 November 2023no edit summary
| Line 74: | Line 74: | ||
*CK34betaE12 -ve. | *CK34betaE12 -ve. | ||
**Usually positive in [[clear cell papillary renal cell tumour]]. | **Usually positive in [[clear cell papillary renal cell tumour]]. | ||
Others: | |||
*GPNMB -ve. | |||
**TSC1/TSC2/MTOR mutated RCC is GPNMB +ve.<ref name=pmid37661807>{{cite journal |authors=Li H, Argani P, Halper-Stromberg E, Lotan TL, Merino MJ, Reuter VE, Matoso A |title=Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others |journal=Am J Surg Pathol |volume=47 |issue=11 |pages=1267–1273 |date=November 2023 |pmid=37661807 |doi=10.1097/PAS.0000000000002117 |url=}}</ref> | |||
===Comparison between some renal tumours with clear cells=== | ===Comparison between some renal tumours with clear cells=== | ||